PIRS - Pieris Pharmaceuticals Inc Qarzning balans kapitallashuviga nisbati

Pieris Pharmaceuticals Inc (PIRS) grafik logotipi

Pieris Pharmaceuticals (PIRS) kompaniyasining biznes likvidligi Anticalin proteinlarining muvaffaqiyati va hamkorlik to'lovlariga bog'liq. Moliyalashtirish tuzilmasi, xususan, umumiy GURU.Markets platformasi grafigidagi qarzning kitob qiymatiga nisbati kapital barqarorligini namoyish etadi, bunda 0.09 joriy parametr qiymati vazifasini bajaradi. Ushbu ko'rsatkich FDA tibbiy qoidalariga qat'iy rioya qilish hamda respirator va onkologik patologiya segmentlari doirasidagi kengayish strategiyasi bilan korrelyatsiyaga ega.

PIRS (Pieris Pharma) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 28.10.2026gacha

Pieris Pharmaceuticals Inc (PIRS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Pieris Pharmaceuticals|PIRS - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Pieris Pharma|PIRS - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Pieris Pharmaceuticals|PIRS - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati pieris.com|PIRS - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Pieris Pharmaceuticals|PIRS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Pieris|PIRS - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Pieris Pharma
Kompaniyaning barcha koʻrsatkichlari tahlili:PIRS Pieris Pharmaceuticals
Pieris asosiy tovari

Ushbu koeffitsiyent qarz mablag'larining kapitalga nisbatini o'lchab, biznesning qarz yuklamasi darajasini belgilaydi. Pieris Pharmaceuticals (PIRS) uchun ushbu muvozanat juda muhimdir, chunki aktivlar qiymati Anticalin platformasi patentlari va litsenziyalash daromadlari bilan ta'minlanadi. Balans hisoboti kapitaliga asoslangan moliyaviy qaramlik darajalarini tahlil qilish orqali investor leveraj dinamikasini kuzatishi mumkin. O'sish tendentsiyasi likvidlik xavfini signalizatsiya qiladi, doimiy past ko'rsatkich esa modelning fundamental barqarorligini tasdiqlaydi.

Pieris Pharmaceuticals raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Liquidia (LQDA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GLPG (Galapagos N.V.)|ANIP: Qarzning balans kapitallashuviga nisbati|MNKD - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Amphastar Pharmaceuticals AMPH|PCRX - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar ARS Pharmaceuticals, Inc. SPRY|Theravance Biopharma Inc (TBPH) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar AQST (Aquestive Pharma)|Balans qiymatiga qarzlar SCPH|Tectonic Therapeutic, Inc. (TECX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati TNXP (tonixpharma.com)|China SXT Pharmaceuticals, Inc. (SXTC) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Eupraxia Pharmaceuticals, Inc. EPRX|Balans kapitallashuviga qarzlar BHST (BioHarvest)|EXOZ - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar ORMP|ENTX (Entera Bio) - Balans qiymatiga qarzlar|HYFT - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati ABVC BioPharma Inc.|CPIX (Cumberland Pharma) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar QNTM (Quantum BioPharma Corp)|Qarzning balans kapitallashuviga nisbati FGEN|TELO - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati Rani Therapeutics Inc (RANI)|SNYR: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati rallybio.com (RLYB)|Lexaria Bioscience Corp. (LEXX) - Qarzlarning balans kapitallashuviga nisbati|PULM - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Pheton|Balans kapitallashuviga qarzlar APM|Balans kapitallashuviga qarzlar LYRA (Lyra Therapeutics Inc.)|Qarzning balans kapitallashuviga nisbati Impact BioMedical Inc|TNF Pharmaceuticals Inc. - Qarzning sof aktivlarga nisbati|YCBD: Qarzning balans kapitallashuviga nisbati|PRFX - Qarzning balans qiymatiga nisbati|CYTO: Balans kapitallashuviga qarzlar|Lipella Pharmaceuticals Inc (LIPO) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar OPTN|Qarzning balans qiymatiga nisbati Procaps Group Corp|Petros Pharmaceuticals - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar qlsyy.net QLI|Qarzning balans qiymatiga nisbati SLRN (ACELYRIN)|TFFP - Balans kapitallashuviga qarzlar